## ALL: Allstate Corporation (The) - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.23 indicates fundamental undervaluation. Quality metrics strong (ROE 34%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($197.37)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Chubb plans 20% staff reduction in next few years as it moves to AI**
- Source: Repairer Driven News | 20251216T130744 | Neutral | Relevance: 65%
- Chubb plans to reduce its staff by 20% over the next three to four years, transitioning 85% of its major underwriting and claims processes to automated systems, driven by AI and process automation. This digital transformation will impact 70% of the company and is projected to result in a 1.5% combined ratio points in expense savings. The company has already invested significantly in data centers and boasts over 3,500 engineers to support this shift.

**2. Chubb's Kelsie Bicking applies product focus to insurtech**
- Source: Digital Insurance | 20251216T200800 | Neutral | Relevance: 64%
- Kelsie Bicking, VP of agent experience at Chubb, leverages her strong product-focused background to enhance the insurer's Marketplace platform for agents. She works on improving agent-facing tools and developing new products by understanding the agents' needs through a "product lens" rather than purely technological one. Her efforts have recently expanded Marketplace to include lower middle-market businesses and incorporate agent feedback into new features.

**3. Is It Too Late To Consider Chubb After Its Strong Multi Year Share Price Run?**
- Source: Simply Wall Street | 20251216T140810 | Somewhat-Bullish | Relevance: 62%
- Chubb has seen significant share price appreciation over the past few years, with a 54% gain over 3 years and 122.5% over 5 years. Despite this, Simply Wall St's valuation framework suggests the stock is currently undervalued, scoring 4 out of 6 checks. The Excess Returns model indicates Chubb is approximately 51.3% undervalued, while its PE ratio of 12.72x is below its calculated Fair Ratio of 13.68x, suggesting modest undervaluation.

**4. Caxton Associates LLP Makes New $1.10 Million Investment in UFP Industries, Inc. $UFPI**
- Source: MarketBeat | 20251216T090834 | Neutral | Relevance: 62%
- Caxton Associates LLP has made a new investment of approximately $1.10 million in UFP Industries, Inc. (NASDAQ:UFPI), acquiring 11,059 shares in the second quarter. This comes as UFP Industries reported a Q2 earnings miss with $1.29 EPS vs $1.37 consensus and revenue of $1.56 billion, down 5.4% year-over-year. Analyst ratings are mixed, with a consensus "Hold" rating and a $114.25 price target.

**5. Morgan Stanley upgrades Lemonade stock rating to Equalweight, sets $85 target**
- Source: Investing.com | 20251216T094302 | Somewhat-Bullish | Relevance: 60%
- Morgan Stanley upgraded Lemonade Inc. (NYSE:LMND) from Underweight to Equalweight, setting an $85 price target due to consistent growth in its Car segment, improved loss ratios, and a clear path to generating EBITDA profitability by Q4 2026. The firm noted Lemonade's strong financial position with over $1 billion in cash and investments, allowing it to fund future growth without additional capital. This upgrade comes despite a softening personal auto insurance underwriting cycle, with Morgan Stanley highlighting Lemonade's significant growth opportunities compared to legacy insurers.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | William Blair | $0 | $0 | 0% |
| 2025-12-16 | Mizuho | $254 | $0 | 0% |
| 2025-12-16 | Morgan Stanley | $215 | $245 | -12% |
| 2025-11-26 | Roth Capital | $240 | $230 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | William Blair | down | Market Perform |
| 2025-12-16 | Mizuho | init | Outperform |
| 2025-12-16 | Morgan Stanley | down | Equal-Weight |
| 2025-11-26 | Roth Capital | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.12M) |
| Sells | 12 ($11.17M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (-0.3%)
- Blackrock Inc.: 8.5% (-1.0%)
- Price (T.Rowe) Assoc: 4.9% (-17.0%)
- State Street Corpora: 4.5% (+0.7%)
- Geode Capital Manage: 2.7% (+3.3%)

### Key Risks

1. Heavy insider selling: $11M sold (12 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.23 suggests fair value with growth premium. Quality metrics strong (ROE 34%). Balance sheet: strong liquidity (30938000000.0x), $3.2B free cash flow. Insider selling cluster ($11.2M in 90 days), potential headwind. Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $54.0B |
| Beta | 0.25 |
| 52W Range | $176.00 - $215.89 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.23 |
| Forward P/E | 8.5 |
| Current P/E | 7.2 |
| YoY Growth | -15.6% |
| EPS Direction | RISING |

### Technicals

MRS_20 stable at -0.8% (minimal 5-day change). Below STRENGTH zone by 4.8pp (needs >4.0% for momentum thesis). Underperforming sector by 3.5pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.01x) but short-term weakness (below SMA20). RSI neutral at 47. OFD pattern: -STN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.78% (CS: 34) | Neutral |
| RSI_14 | 47.2 | Neutral |
| MACD Histogram | -0.20 | Bearish |
| vs SMA20 | 0.984x | Below |
| vs SMA50 | 1.008x | Above |
| vs SMA200 | 1.015x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $205.03
- **Stop Loss:** $197.37 (3.7% risk)
- **Target:** $220.35 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 93
- **Position Value:** $19,067.79
- **Portfolio %:** 19.07%
- **Risk Dollars:** $712.50
- **Risk Per Trade:** 0.71%
- **Modifiers:** L1 95% | L2 75% | Combined 0.71x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-04 (Est: $8.25)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $7.54 | $11.17 | +48.1% |
| 2025Q2 | $3.26 | $5.94 | +82.4% |
| 2025Q1 | $2.53 | $3.53 | +39.3% |
| 2024Q4 | $6.28 | $7.67 | +22.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*